Show simple item record

Symptomatic therapy in multiple sclerosis: Big pharma should do moreYES

dc.contributor.authorKantarci, Orhun
dc.contributor.authorSiva, Aksel
dc.date.accessioned2021-03-06T10:38:14Z
dc.date.available2021-03-06T10:38:14Z
dc.date.issued2015
dc.identifier.citationSiva A., Kantarci O., "Symptomatic therapy in multiple sclerosis: Big pharma should do moreYES", MULTIPLE SCLEROSIS JOURNAL, cilt.21, ss.980-982, 2015
dc.identifier.issn1352-4585
dc.identifier.othervv_1032021
dc.identifier.otherav_eb4ee27e-bcca-49ca-86f2-1fbf7711d55b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/154534
dc.identifier.urihttps://doi.org/10.1177/1352458515588974
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSinirbilim ve Davranış
dc.subjectNEUROSCIENCES
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleSymptomatic therapy in multiple sclerosis: Big pharma should do moreYES
dc.typeMakale
dc.relation.journalMULTIPLE SCLEROSIS JOURNAL
dc.contributor.departmentMayo Clinic , ,
dc.identifier.volume21
dc.identifier.issue8
dc.identifier.startpage980
dc.identifier.endpage982
dc.contributor.firstauthorID223217


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record